115 related articles for article (PubMed ID: 33770537)
1. PCTP contributes to human platelet activation by enhancing dense granule secretion.
Abraham S; Ma L; Kong X; Askari S; Edelstein LC; McKenzie SE
Thromb Res; 2021 Jun; 202():67-73. PubMed ID: 33770537
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
Rigg RA; Healy LD; Chu TT; Ngo ATP; Mitrugno A; Zilberman-Rudenko J; Aslan JE; Hinds MT; Vecchiarelli LD; Morgan TK; Gruber A; Temple KJ; Lindsley CW; Duvernay MT; Hamm HE; McCarty OJT
Platelets; 2019; 30(1):126-135. PubMed ID: 30560697
[TBL] [Abstract][Full Text] [Related]
3. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
4. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c.
Edelstein LC; Simon LM; Montoya RT; Holinstat M; Chen ES; Bergeron A; Kong X; Nagalla S; Mohandas N; Cohen DE; Dong JF; Shaw C; Bray PF
Nat Med; 2013 Dec; 19(12):1609-16. PubMed ID: 24216752
[TBL] [Abstract][Full Text] [Related]
6. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.
Marjoram RJ; Voss B; Pan Y; Dickeson SK; Zutter MM; Hamm HE; Santoro SA
J Biol Chem; 2009 Dec; 284(50):34640-7. PubMed ID: 19815553
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
9. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
10. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
Covic L; Gresser AL; Kuliopulos A
Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
12. Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice.
Renna SA; Michael JV; Kong X; Ma L; Ma P; Nieman MT; Edelstein LC; McKenzie SE
J Thromb Haemost; 2022 May; 20(5):1236-1247. PubMed ID: 35152546
[TBL] [Abstract][Full Text] [Related]
13. Assessment of neonatal, cord, and adult platelet granule trafficking and secretion.
Ngo ATP; Sheriff J; Rocheleau AD; Bucher M; Jones KR; Sepp AI; Malone LE; Zigomalas A; Maloyan A; Bahou WF; Bluestein D; McCarty OJT; Haley KM
Platelets; 2020; 31(1):68-78. PubMed ID: 30810440
[TBL] [Abstract][Full Text] [Related]
14. The C-Type Lectin Receptor CD93 Regulates Platelet Activation and Surface Expression of the Protease Activated Receptor 4.
Trivigno SMG; Vismara M; Canobbio I; Rustichelli S; Galvagni F; Orlandini M; Torti M; Guidetti GF
Thromb Haemost; 2024 Feb; 124(2):122-134. PubMed ID: 37669782
[TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway.
Holinstat M; Voss B; Bilodeau ML; Hamm HE
Mol Pharmacol; 2007 Mar; 71(3):686-94. PubMed ID: 17151288
[TBL] [Abstract][Full Text] [Related]
16. Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.
Arachiche A; de la Fuente M; Nieman MT
PLoS One; 2013; 8(2):e55740. PubMed ID: 23405206
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of proteinase-activated receptor agonists on human platelets.
Chung AW; Jurasz P; Hollenberg MD; Radomski MW
Br J Pharmacol; 2002 Mar; 135(5):1123-32. PubMed ID: 11877318
[TBL] [Abstract][Full Text] [Related]
18. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
[TBL] [Abstract][Full Text] [Related]
20. Differential role of protein kinase C delta isoform in agonist-induced dense granule secretion in human platelets.
Murugappan S; Tuluc F; Dorsam RT; Shankar H; Kunapuli SP
J Biol Chem; 2004 Jan; 279(4):2360-7. PubMed ID: 14578358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
